RecruitingNCT07476495

Insights on Dissemination of Lung Cancer


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

100 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how lung cancer spreads in patients with early-stage non-small cell lung cancer (NSCLC) who are having surgery. By collecting and analyzing tumor tissue and blood samples during and after surgery, researchers hope to better understand the biology of cancer spread and improve future treatments. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with resectable (surgically removable) stage IA to IIIA non-small cell lung cancer (adenocarcinoma or squamous cell carcinoma) - You are considered fit for surgery, possibly combined with other treatments **You may NOT be eligible if...** - Your lung cancer is a different type other than adenocarcinoma or squamous cell carcinoma - You have or have recently had another cancer being treated with systemic therapy (within the last 3 years) - You do not require surgery as part of your treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS Azienda Ospedaliero-Università di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07476495